Fulcrum Therapeutics, Inc. (FULC) Social Stream
FULCRUM THERAPEUTICS INC (FULC) Price Targets From Analysts
Use the tables below to see what analysts covering FULCRUM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-10 | 6 | $46 | $16 | $36.333 | $7.53 | 382.51% |
| 2022-02-01 | 6 | $46 | $16 | $34.833 | $7.53 | 362.59% |
| 2022-03-04 | 6 | $46 | $16 | $34.833 | $7.53 | 362.59% |
| 2022-03-07 | 6 | $43 | $16 | $33.833 | $7.53 | 349.31% |
| 2022-03-08 | 7 | $43 | $16 | $33.714 | $7.53 | 347.73% |
| 2022-03-30 | 7 | $43 | $18 | $34 | $7.53 | 351.53% |
| 2022-05-10 | 7 | $43 | $18 | $34.142 | $7.53 | 353.41% |
| 2022-05-27 | 7 | $43 | $18 | $33 | $7.53 | 338.25% |
| 2022-06-13 | 7 | $43 | $18 | $30.142 | $7.53 | 300.29% |
| 2022-08-17 | 7 | $43 | $7 | $28.571 | $7.53 | 279.43% |
| 2022-10-12 | 7 | $43 | $8 | $28.714 | $7.53 | 281.33% |
| 2022-11-08 | 7 | $42 | $8 | $27.571 | $7.53 | 266.15% |
| 2022-11-11 | 7 | $35 | $8 | $23.714 | $7.53 | 214.93% |
| 2022-11-14 | 8 | $35 | $8 | $23.857 | $7.53 | 216.83% |
| 2023-01-19 | 8 | $35 | $8 | $21.75 | $7.53 | 188.84% |
| 2023-01-22 | 8 | $35 | $8 | $22.125 | $7.53 | 193.82% |
| 2023-01-24 | 8 | $35 | $7 | $22.125 | $7.53 | 193.82% |
| 2023-02-08 | 8 | $35 | $8 | $22.25 | $7.53 | 195.48% |
| 2023-02-27 | 8 | $35 | $5 | $17.25 | $7.53 | 129.08% |
| 2023-02-28 | 8 | $35 | $5 | $17.555 | $7.53 | 133.13% |
| 2023-03-10 | 8 | $35 | $5 | $17.555 | $7.53 | 133.13% |
| 2023-03-13 | 7 | $20 | $5 | $11.125 | $7.53 | 47.74% |
| 2023-05-15 | 7 | $20 | $3 | $10.375 | $7.53 | 37.78% |
| 2023-05-16 | 7 | $20 | $3 | $9.25 | $7.53 | 22.84% |
| 2023-08-04 | 7 | $20 | $3 | $9.125 | $7.53 | 21.18% |
| 2023-08-22 | 7 | $20 | $3 | $9.125 | $7.53 | 21.18% |
| 2023-08-23 | 7 | $20 | $3 | $11.187 | $7.53 | 48.57% |
| 2023-11-13 | 7 | $20 | $4.5 | $11.437 | $7.53 | 51.89% |
The Trend in the Analyst Price Target
Over the past 52 weeks, FULC's average price target has gone down $10.81.
FULC reports an average of 138.27% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-19 | 8 | 35 | 8.0 | 21.750 | 12.15 | 79.01% |
| 2023-03-10 | 8 | 35 | 5.0 | 17.555 | 4.51 | 289.25% |
| 2023-03-10 | 8 | 20 | 5.0 | 10.888 | 4.51 | 141.42% |
| 2023-03-13 | 7 | 20 | 5.0 | 11.125 | 4.50 | 147.22% |
| 2023-09-25 | 7 | 20 | 4.5 | 11.437 | 4.20 | 172.31% |
FULC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.71 | 5 | 0 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
FULC's average broker recommendation rating worsened by 0.71 over the prior 42 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, FULCRUM THERAPEUTICS INC's variance in analysts' estimates is lower than -2794.05% of them.
- FULCRUM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 2578.22% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, FULCRUM THERAPEUTICS INC's number of analysts covering the stock is higher than 2636.97% of them.
- In the context of stocks in the small market cap category, FULCRUM THERAPEUTICS INC's average analyst price target is higher than 1760.8% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to FULCRUM THERAPEUTICS INC are BCYC, CELU, and APLT.
View All Top Stocks by Price Target
Is FULC a Buy, Hold or Sell? See the POWR Ratings now!